Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy

Prokop Vodička; Tarec C El-Galaly; Vit Prochazka; Christopher R Flowers; Diego Villa; Caroline E Dietrich; Lasse H Jakobsen; Hervé Ghesquieres; Michael R Clausen; Robert Kridel; Chan Y Cheah; Eliza A Hawkes; Björn E Wahlin; Maher K Gandhi; Melissa C Larson; Elliot J Cahn; Jonathan W Friedberg; Peter Martin; Dai Chihara; Jonathon B Cohen; Thomas M Habermann; Carla Casulo; Yucai Wang; Peter de Nully Brown; Eric Mou; David Belada; Andrea Janikova; Heidi Mocikova; Richard Burack; Izidore S Lossos; Brad S Kahl; Karin E Smedby; Laurie H Sehn; Marek Trněný; James R Cerhan; Matthew J Maurer

doi:10.1182/blood.2026033090

Back

Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy

Journal article

Peer reviewed

Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy

Prokop Vodička, Tarec C El-Galaly, Vit Prochazka, Christopher R Flowers, Diego Villa, Caroline E Dietrich, Lasse H Jakobsen, Hervé Ghesquieres, Michael R Clausen, Robert Kridel, …

Blood

04/14/2026

DOI: 10.1182/blood.2026033090

PMID: 41980013

View Online

Abstract

Short diagnosis-to-treatment interval independently predicts inferior outcomes in follicular lymphoma. Using international discovery and validation cohorts, we demonstrate its prognostic value beyond established prognostic indices, with implications for risk stratification, clinical trial design, and interpretation.

Details

Title: Subtitle: Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy
Creators: Prokop Vodička - Mayo Clinic
Tarec C El-Galaly - Aarhus University Hospital
Vit Prochazka - University Hospital Olomouc
Christopher R Flowers - The University of Texas MD Anderson Cancer Center
Diego Villa - BC Cancer Agency
Caroline E Dietrich - Karolinska Institutet
Lasse H Jakobsen - Aalborg University Hospital
Hervé Ghesquieres - Université Claude Bernard Lyon 1
Michael R Clausen - Vejle Sygehus
Robert Kridel - Princess Margaret Cancer Centre
Chan Y Cheah - Sir Charles Gairdner Hospital
Eliza A Hawkes - Austin Health
Björn E Wahlin - Karolinska Institutet
Maher K Gandhi - The University of Queensland
Melissa C Larson - Mayo Clinic
Elliot J Cahn - Mayo Clinic
Jonathan W Friedberg - University of Rochester
Peter Martin - NYU Langone Health
Dai Chihara - The University of Texas MD Anderson Cancer Center
Jonathon B Cohen - Emory University
Thomas M Habermann - Mayo Clinic
Carla Casulo - University of Rochester Medical Center
Yucai Wang - Mayo Clinic
Peter de Nully Brown - Rigshospitalet
Eric Mou - University of Iowa
David Belada - University Hospital Hradec Králové
Andrea Janikova - University Hospital Brno
Heidi Mocikova - Charles University
Richard Burack - University of Rochester
Izidore S Lossos - University of Miami
Brad S Kahl - Washington University in St. Louis
Karin E Smedby - Karolinska Institutet
Laurie H Sehn - University of British Columbia
Marek Trněný - Charles University
James R Cerhan - Mayo Clinic
Matthew J Maurer - Mayo Clinic
Resource Type: Journal article
Publication Details: Blood
DOI: 10.1182/blood.2026033090
PMID: 41980013
NLM abbreviation: Blood
ISSN: 0006-4971
eISSN: 1528-0020
Publisher: American Society of Hematology
Language: English
Electronic publication date: 04/14/2026
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
Record Identifier: 9985153516302771

Metrics

1 Record Views